Logo

Hyseq Pockets $15M in Private Stock Placement

Apr 10, 2002

NEW YORK, April 10 - Hyseq Pharmaceuticals said yesterday it has pocketed about $15 million in a private stock placement.

Investors, which included new and existing institutional investors, bought roughly 3.6 million shares of newly issued common stock at $4.20 per share.

Hyseq said it also issued warrants to the investors to buy approximately 894,000 additional shares for $5.67 apiece, or a 35 percent premium to the per-unit purchase price. 

Breaking News
The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.